v3.25.2
Share-Based Compensation (Details Narrative) - Sonnet BioTherapeutics Holdings, Inc. [Member] - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Jul. 08, 2026
Jan. 01, 2025
Jan. 01, 2024
Jan. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Jun. 30, 2025
Sep. 30, 2024
Sep. 30, 2023
Jul. 09, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Vesting percentage   100.00%                  
Forecast [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Vesting percentage   100.00%                  
Restricted Stock Units (RSUs) [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of shares granted     9,175           9,175 976  
Restricted stock units and vesting rights, description         In December of 2022, 976 RSUs were granted, 100% of which vested on January 1, 2024. In December of 2021, 259 RSUs were granted, 100% of which vested on January 1, 2023. In March of 2021, an additional 19 RSUs were granted, 50% of which vested on March 25, 2022 and the remaining 50% vested on March 25, 2023.        
Number of shares granted         976 259 19        
Restricted stock, shares issued       688              
Stock compensation modification, incremental expense       $ 38,837              
Unrecognized compensation expense               $ 0 $ 32,314    
Restricted Stock Units (RSUs) [Member] | Subsequent Event [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Vesting percentage 100.00%                    
Shares issued                     120,000
Restricted Stock Units (RSUs) [Member] | Maximum [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Weighted average period                 3 months    
Restricted Stock Awards (RSA) [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of shares granted     7,977         7,977 7,977 688  
Unrecognized compensation expense               $ 0 $ 28,080    
Restricted Stock Awards (RSA) [Member] | Maximum [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Weighted average period                 3 months    
2020 Omnibus Equity Incentive Plan [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of shares available for issuance               120,302      
2020 Omnibus Equity Incentive Plan [Member] | Common Stock [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Number of shares available for issuance     17,157           5